Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue SUPPL., 1999, Pages

  Clive, S ^a   Gardiner, J ^a   Leonard, R C F ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cutaneous breast cancer; Cytostatic; Miltefosine; Topical therapy

Indexed keywords

MILTEFOSINE;

ADULT; AGED; BREAST CARCINOMA; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SKIN METASTASIS; SKIN TOXICITY; TREATMENT OUTCOME; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0033380515     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051114     Document Type: Conference Paper

References (4)

1. Dummer R, Krasovec M, Roger J, Sindermann H, Burg G (1993) Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of phase I/II study. J Am Acad Dermatol 29: 963-970
2. Unger C, Sindermann H, Peukert M, Hilgard P, Engel J, Eibl H (1992) Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Prog Exp Tumor Res 34: 153-159
3. Überall F, Oberhuber H, Maly K, Zaknun J, Demuth L, Grunicke HH (1991) Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 51: 807-812
4. Sindermann H, Junge K, Burk K (1994) Miltefosine solution: prognostic factors for the outcome of topical treatment of skin metastatic breast cancer. Onkologie 17: 21-26